Daniel Azorín
30 Papers
185 Citations
Daniel Azorín is an academic researcher. The author has contributed to research in topics: Sarcoma & Medicine. The author has an hindex of 12, co-authored 29 publications.
Chat about Author
Papers
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma
Joan Enric Ramis-Zaldivar,Blanca Gonzalez-Farre,Olga Balagué,Veronica Celis,Ferran Nadeu,Julia Salmeron-Villalobos,Mara Andrés,Idoia Martin-Guerrero,Marta Garrido-Pontnou,Ayman Gaafar,Mariona Suñol,Carmen Bárcena,Federico Garcia-Bragado,Maitane Andión,Daniel Azorín,Itziar Astigarraga,Maria Sagaseta de Ilurdoz,Constantino Sábado,Soledad Gallego,Jaime Verdu-Amoros,Rafael Fernandez-Delgado,Vanesa Perez,Gustavo Tapia,Anna Mozos,Montserrat Torrent,Palma Solano-Páez,Alfredo Rivas-Delgado,Ivan Dlouhy,Guillem Clot,Anna Enjuanes,Armando López-Guillermo,Pallavi Galera,Matthew J. Oberley,Alanna Maguire,Colleen Ramsower,Lisa M. Rimsza,Leticia Quintanilla-Martinez,Elaine S. Jaffe,Elias Campo,Itziar Salaverria +39 more
TL;DR: The molecular heterogeneity of pediatric and young adult LBCL is unraveled, the classification of this group of tumors is improved, and new parameters for risk stratification are provided.
102
Cholecystokinin Down-Regulation by RNA Interference Impairs Ewing Tumor Growth
Jaime Carrillo,Eva García-Aragoncillo,Daniel Azorín,Noelia Agra,Ana Sastre,Imelda González-Mediero,Purificación García-Miguel,Angel Pestaña,Soledad Gallego,Dolores Segura,Javier Alonso +10 more
TL;DR: The hypothesis that cholecystokinin acts as an autocrine growth factor stimulating the proliferation of Ewing cells is supported and therapies targeting CCK could be promising in the treatment of EWing tumors is suggested.
84
Efficacy of ATR inhibitors as single agents in Ewing sarcoma
Maria Nieto-Soler,Isabel Morgado-Palacin,Vanesa Lafarga,Emilio Lecona,Matilde Murga,Elsa Callen,Daniel Azorín,Javier Alonso,Andrés J. López-Contreras,André Nussenzweig,Oscar Fernandez-Capetillo +10 more
TL;DR: It is shown that ES suffer from high endogenous levels of RS, rendering them particularly dependent on the ATR pathway, and ATR inhibitors are identified as a potential therapy for Ewing Sarcomas.
Folliculocystic and collagen hamartoma of tuberous sclerosis complex
Antonio Torrelo,Smail Hadj-Rabia,Isabel Colmenero,Robert Piston,Virginia P. Sybert,Helena Hilari-Carbonell,Angela Hernández-Martín,Joan Carles Ferreres,Sergio Vano-Galvan,Daniel Azorín,Javier Salamanca,Luis Requena,Christine Bodemer,Rudolf Happle,Vicente García-Patos,Sylvie Fraitag +15 more
TL;DR: This distinctive folliculocystic and collagen hamartoma has not been recognized previously in association with TSC and is likely to be new to the literature.
47
Primary cutaneous adenosquamous carcinoma: a case report and review of the literature.
Daniel Azorín,Fernando Lopez-Rios,Claudio Ballestín,Nuria Barrientos,José Luis Rodríguez-Peralto +4 more
TL;DR: A primary cutaneous ASC is reported, which is a rare but distinctive neoplasm that usually exhibits an aggressive course and has been used for tumors with better prognosis, such as mucoepidermoid carcinomas and acantolytic squamous cell carcinomas, originating confusion.
39